Monogram Orthopaedics (MGRM) Projected to Post Quarterly Earnings on Wednesday

Monogram Orthopaedics (NASDAQ:MGRM) is projected to issue its quarterly earnings data after the market closes on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.11) per share for the quarter.

Monogram Orthopaedics Price Performance

Shares of MGRM stock opened at $2.24 on Tuesday. The company has a market cap of $76.86 million, a P/E ratio of -4.77 and a beta of 1.66. The stock’s 50-day moving average is $2.55 and its 200 day moving average is $2.51. Monogram Orthopaedics has a 1-year low of $1.53 and a 1-year high of $4.90.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on MGRM shares. Roth Mkm started coverage on Monogram Orthopaedics in a report on Monday, December 9th. They issued a “buy” rating and a $4.00 price target for the company. Roth Capital raised Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.